|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"teng cm"
Showing items 1-25 of 190 (8 Page(s) Totally)
1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page
| 臺北醫學大學 |
2015 |
MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27
|
Pai, HC;Kumar, S;Shen, CC;Liou, JP;Pan, SL;Teng, CM |
| 臺北醫學大學 |
2015 |
Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo
|
Huang, HL;Peng, CY;Lai, MJ;Chen, CH;Lee, HY;Wang, JC;Liou, JP;Pan, SL;Teng, CM. |
| 中國醫藥大學 |
2014-12 |
Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo.
|
(Huang HL);彭婕妤(Chieh-Yu Peng);(Lai MJ);(Chen CH);(Lee HY);(Wang JC);(Liou JP)*;(Pan SL)*;(Teng CM)* |
| 國家衛生研究院 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL |
| 亞洲大學 |
2014-04 |
YC-1 inhibits proliferation of breast cancer cells by downregulating EZH2 expression via activation of c-Cbl and ERK
|
Chang, LC;Chang, LC;Lin, HY;Lin, HY;Tsai, MT;Tsai, MT;鄒瑞煌;Chou, Ruey-Hwang;Lee, FY;Lee, FY;Teng, CM;Teng, CM;Hsieh, MT;Hsieh, MT;Hung, HY;Hung, HY;Huang LJ, ;余永倫;Kuo, SC;Kuo, SC; |
| 臺北醫學大學 |
2014 |
NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells
|
Wu, SY;Pan, SL;Xiao, ZY;Hsu, JL;Chen, MC;Lee, KH;Teng, CM |
| 臺北醫學大學 |
2014 |
A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin
|
Wang, LT;Liou, JP;Li, YH;Liu, YM;Pan, SL;Teng, CM |
| 臺北醫學大學 |
2014 |
Indolyl or Indolinyl hydroxamate compounds
|
Chen, CS;Liou, JP;Liu, HJ;Hung, KS;Shan, PW;Chiu, WT;Teng, CM |
| 臺北醫學大學 |
2014 |
In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL |
| 臺北醫學大學 |
2014 |
Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity
|
Mehndiratta, S;Hsieh, YL;Liu, YM;Wang, AW;Lee, HY;Liang, LY;Kumar, S;Teng, CM;CR*, Yang;Liou, JP*. |
| 臺北醫學大學 |
2014 |
K20E, an oxidative-coupling compound of methyl caffeate, exhibits anti-angiogenic activities through down-regulations of VEGF and VEGF receptor-2
|
Lee, HY;Wang, LT;Li, YH;Pan, SL;Chen, YL;Teng, CM;Liou, JP |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL. |
| 臺北醫學大學 |
2014 |
In vitro and in vivo antitumor effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
Tsai, AC;Pai, HC;Wang, CY;Liou, JP;Teng, CM;Wang, JC;Pan, SL |
| 國家衛生研究院 |
2013-08 |
Activated PAR-2 regulates pancreatic cancer progression through ILK/HIF-alpha–induced TGF-alpha expression and MEK/VEGF-A–mediated angiogenesis
|
Chang, LH;Pan, SL;Lai, CY;Tsai, AC;Teng, CM |
| 國家衛生研究院 |
2013-07-08 |
1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors
|
Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh, TK;Li, YH;Mehndiratta, S;Teng, CM;Liou, JP |
| 國家衛生研究院 |
2013-07-08 |
Inside Cover: 1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressors(ChemBioChem 10/2013)
|
Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh, TK;Li, YH;Mehndiratta, S;Teng, CM;Liou, JP |
| 國家衛生研究院 |
2013-04 |
MPT0G066, a novel microtubule-destabilizing agent, induces cell apoptosis and potentiates antineoplastic effects of cisplatin in human ovarian cancer cells in vitro and in vivo
|
Chen, CH;Li, YC;Chang, LH;Liou, JP;Pan, SL;Teng, CM |
| 國家衛生研究院 |
2013-03 |
Moscatilin inhibits migration and metastasis of human breast cancer MDA-MB-231 cells through inhibition of Akt and Twist signaling pathway
|
Pai, HC;Chang, LH;Peng, CY;Chang, YL;Chen, CC;Shen, CC;Teng, CM;Pan, SL |
| 國家衛生研究院 |
2013-02 |
Azatyrosinamides: Novel RAS-related anticancer agents
|
Wang, CL;Lee, O;Huang, CF;Li, EIC;Teng, CM;Pan, SL;Lian, JF;Chang, FS;Liou, JP;Wang, HP |
| 臺北醫學大學 |
2013 |
Denbinobin induces human glioblastoma multiforme cell apoptosis through the IKKα-Akt-FKHR signaling cascade
|
Wen, HY;Hsu, MJ;Chen, CC;Chen, BC;Hong, CY;Teng, CM;Pan, SL;Chiu, WT;Lin, CH |
| 臺北醫學大學 |
2013 |
Azatyrosinamides: Novel Ras-related Anticancer Agents
|
Wang, CL;On, Lee;Huang, CF;Li Eric, IC;Teng, CM;Pan, SL;Lian, JF;Chang, FS; |
| 臺北醫學大學 |
2013 |
TW01001, a novel piperazinedione , induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells
|
Chen, MC;Chen, CH;Liu, YN;Wang, HP;Pan, SL;Teng, CM |
| 臺北醫學大學 |
2013 |
1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors
|
Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh TK.Li, YH;Mehndiratta, S;Teng, CM;JP*, Liou |
| 國家衛生研究院 |
2012-09-06 |
Alpha-tomatine-mediated anti-cancer activity in vitro and in vivo through cell cycle- and caspase-independent pathways
|
Chao, MW;Chen, CH;Chang, YL;Teng, CM;Pan, SL |
| 國家衛生研究院 |
2012-08-22 |
Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo
|
Huang, HL;Lee, HY;Tsai, AC;Peng, CY;Lai, MJ;Wang, JC;Pan, SL;Teng, CM;Liou, JP |
Showing items 1-25 of 190 (8 Page(s) Totally)
1 2 3 4 5 6 7 8 > >>
View [10|25|50] records per page
|
